{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:39:24Z","timestamp":1788262764144,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1U01AI115520"],"award-info":[{"award-number":["1U01AI115520"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Melioidosis is a tropical infectious disease caused by\n                    <jats:italic>Burkholderia pseudomallei<\/jats:italic>\n                    that results in high mortality. Hemolysin co-regulated protein 1 (Hcp1) and O-polysaccharide (OPS) are vaccine candidates and potential diagnostic antigens. The correlation of classes\/subclasses of antibodies against these antigens with clinical characteristics of melioidosis patients is unknown. Antibodies in plasma samples from melioidosis patients and healthy donors were quantified by ELISA and compared with clinical features. In melioidosis patients, Hcp1 induced high IgG levels. OPS induced high IgG and IgA levels. The area under receiver operating characteristic curve (AUROCC) to discriminate melioidosis cases from healthy donors was highest for anti-Hcp1 IgG (0.92) compared to anti-Hcp1 IgA or IgM. In contrast, AUROCC for anti-OPS for IgG (0.91) and IgA (0.92) were comparable. Anti-Hcp1 IgG1 and anti-OPS IgG2 had the greatest AUROCCs (0.87 and 0.95, respectively) compared to other IgG subclasses for each antigen. Survivors had significantly higher anti-Hcp1 IgG3 levels than non-survivors. Male melioidosis patients with diabetes had higher anti-OPS IgA levels than males without diabetes. Thus, diverse and specific antibody responses are associated with distinct clinical characteristics in melioidosis, confirming the diagnostic utility of these responses and providing new insights into immune mechanisms.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-48828-4","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T06:03:44Z","timestamp":1569564224000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Distinct classes and subclasses of antibodies to hemolysin co-regulated protein 1 and O-polysaccharide and correlation with clinical characteristics of melioidosis patients"],"prefix":"10.1038","volume":"9","author":[{"given":"Apinya","family":"Pumpuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rungnapa","family":"Phunpang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peeraya","family":"Ekchariyawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adul","family":"Dulsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriorn","family":"Loupha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kochnipa","family":"Kwawong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaowaree","family":"Charoensawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkachai","family":"Thiansukhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P. J.","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary N.","family":"Burtnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Brett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Eoin","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narisara","family":"Chantratita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"issue":"2","key":"48828_CR1","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1128\/CMR.18.2.383-416.2005","volume":"18","author":"AC Cheng","year":"2005","unstructured":"Cheng, A. C. & Currie, B. J. Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev. 18(2), 383\u2013416 (2005).","journal-title":"Clin Microbiol Rev."},{"issue":"3","key":"48828_CR2","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.2807\/esm.10.03.00528-en","volume":"10","author":"AC Cheng","year":"2005","unstructured":"Cheng, A. C., Dance, D. A. & Currie, B. J. Bioterrorism, Glanders and melioidosis. Euro Surveill. 10(3), E1\u20132 (2005).","journal-title":"Euro Surveill."},{"key":"48828_CR3","doi-asserted-by":"publisher","first-page":"15008","DOI":"10.1038\/nmicrobiol.2015.8","volume":"1","author":"D Limmathurotsakul","year":"2016","unstructured":"Limmathurotsakul, D. et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol. 1, 15008 (2016).","journal-title":"Nat Microbiol."},{"key":"48828_CR4","doi-asserted-by":"crossref","unstructured":"Wiersinga, W. J. et al. Melioidosis. Nat Rev Dis Prim. 4 (2018).","DOI":"10.1038\/nrdp.2017.107"},{"issue":"3","key":"48828_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.trstmh.2007.11.005","volume":"102","author":"BJ Currie","year":"2008","unstructured":"Currie, B. J. Advances and remaining uncertainties in the epidemiology of Burkholderia pseudomallei and melioidosis. Trans R Soc Trop Med Hyg. 102(3), 225\u2013227 (2008).","journal-title":"Trans R Soc Trop Med Hyg."},{"issue":"6","key":"48828_CR6","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.4269\/ajtmh.2010.10-0038","volume":"82","author":"D Limmathurotsakul","year":"2010","unstructured":"Limmathurotsakul, D. et al. Increasing incidence of human melioidosis in northeast Thailand. Am J Trop Med Hyg. 82(6), 1113\u20131117 (2010).","journal-title":"Am J Trop Med Hyg."},{"issue":"6","key":"48828_CR7","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.4269\/ajtmh.2006.74.1074","volume":"74","author":"V Wuthiekanun","year":"2006","unstructured":"Wuthiekanun, V. et al. Development of antibodies to Burkholderia pseudomallei during childhood in melioidosis-endemic northeast Thailand. Am J Trop Med Hyg. 74(6), 1074\u20131075 (2006).","journal-title":"Am J Trop Med Hyg."},{"issue":"9","key":"48828_CR8","doi-asserted-by":"publisher","first-page":"e0204509","DOI":"10.1371\/journal.pone.0204509","volume":"13","author":"Viriya Hantrakun","year":"2018","unstructured":"Hantrakun, V. et al. Clinical epidemiology and outcomes of community acquired infection and sepsis among hospitalized patients in a resource limited setting in Northeast Thailand: A prospective observational study (Ubon-sepsis). Plos One. 13(9) (2018).","journal-title":"PLOS ONE"},{"issue":"2","key":"48828_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3201\/eid1402.070811","volume":"14","author":"V Wuthiekanun","year":"2008","unstructured":"Wuthiekanun, V. et al. Burkholderia pseudomallei antibodies in children, Cambodia. Emerg Infect Dis. 14(2), 301\u2013303 (2008).","journal-title":"Emerg Infect Dis."},{"issue":"1","key":"48828_CR10","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s15010-002-3020-2","volume":"31","author":"C Vasu","year":"2003","unstructured":"Vasu, C., Vadivelu, J. & Puthucheary, S. D. The humoral immune response in melioidosis patients during therapy. Infection. 31(1), 24\u201330 (2003).","journal-title":"Infection."},{"issue":"1","key":"48828_CR11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1099\/0022-1317-50-1-55","volume":"50","author":"V Chenthamarakshan","year":"2001","unstructured":"Chenthamarakshan, V., Kumutha, M. V., Vadivelu, J. & Puthucheary, S. D. Distribution of immunoglobulin classes and IgG subclasses against a culture filtrate antigen of Burkholderia pseudomallei in melioidosis patients. J Med Microbiol. 50(1), 55\u201361 (2001).","journal-title":"J Med Microbiol."},{"issue":"3","key":"48828_CR12","doi-asserted-by":"publisher","first-page":"542","DOI":"10.4269\/ajtmh.15-0114","volume":"93","author":"V Suttisunhakul","year":"2015","unstructured":"Suttisunhakul, V. et al. Evaluation of polysaccharide-based latex agglutination assays for the rapid detection of antibodies to Burkholderia pseudomallei. Am J Trop Med Hyg. 93(3), 542\u2013546 (2015).","journal-title":"Am J Trop Med Hyg."},{"issue":"5","key":"48828_CR13","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1128\/JCM.02856-15","volume":"54","author":"V Suttisunhakul","year":"2016","unstructured":"Suttisunhakul, V. et al. Development of rapid enzyme-linked immunosorbent assays for detection of antibodies to Burkholderia pseudomallei. J Clin Microbiol. 54(5), 1259\u20131268 (2016).","journal-title":"J Clin Microbiol."},{"issue":"3","key":"48828_CR14","doi-asserted-by":"publisher","first-page":"e0005499","DOI":"10.1371\/journal.pntd.0005499","volume":"11","author":"A Pumpuang","year":"2017","unstructured":"Pumpuang, A. et al. Comparison of O-polysaccharide and hemolysin co-regulated protein as target antigens for serodiagnosis of melioidosis. PLoS Negl Trop Dis. 11(3), e0005499 (2017).","journal-title":"PLoS Negl Trop Dis."},{"key":"48828_CR15","doi-asserted-by":"crossref","unstructured":"Kohler, C. et al. Rapid and sensitive multiplex detection of Burkholderia pseudomallei-specific antibodies in melioidosis patients based on a protein microarray approach. Plos Neglect Trop D. 10(7) (2016).","DOI":"10.1371\/journal.pntd.0004847"},{"key":"48828_CR16","doi-asserted-by":"crossref","unstructured":"Phokrai, P. et al. A Rapid immunochromatography test based on Hcp1 is a potential point-of-care test for serological diagnosis of melioidosis. J Clin Microb. 56(8) (2018).","DOI":"10.1128\/JCM.00346-18"},{"key":"48828_CR17","doi-asserted-by":"crossref","unstructured":"Burtnick, M. N. et al. Development of subunit vaccines that provide high-level protection and sterilizing immunity against acute inhalational melioidosis. Infect Immun. 86(1) (2018).","DOI":"10.1128\/IAI.00724-17"},{"issue":"9","key":"48828_CR18","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.1128\/iai.65.9.3648-3653.1997","volume":"65","author":"M Ho","year":"1997","unstructured":"Ho, M. et al. Specificity and functional activity of anti-Burkholderia pseudomallei polysaccharide antibodies. Infect Immun. 65(9), 3648\u20133653 (1997).","journal-title":"Infect Immun."},{"issue":"4","key":"48828_CR19","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1128\/IAI.01218-10","volume":"79","author":"MN Burtnick","year":"2011","unstructured":"Burtnick, M. N. et al. The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei. Infect Immun. 79(4), 1512\u20131525 (2011).","journal-title":"Infect Immun."},{"issue":"1","key":"48828_CR20","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1128\/IAI.00985-09","volume":"78","author":"MN Burtnick","year":"2010","unstructured":"Burtnick, M. N., DeShazer, D., Nair, V., Gherardini, F. C. & Brett, P. J. Burkholderia mallei cluster 1 type VI secretion mutants exhibit growth and actin polymerization defects in RAW 264.7 murine macrophages. Infect Immun. 78(1), 88\u201399 (2010).","journal-title":"Infect Immun."},{"key":"48828_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep08235","volume":"5","author":"YT Lim","year":"2015","unstructured":"Lim, Y. T. et al. Extended loop region of Hcp1 is critical for the assembly and function of type VI secretion system in Burkholderia pseudomallei. Sci Rep. 5, 8235 (2015).","journal-title":"Sci Rep."},{"key":"48828_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.micpath.2015.01.006","volume":"79","author":"S Chieng","year":"2015","unstructured":"Chieng, S., Mohamed, R. & Nathan, S. Transcriptome analysis of Burkholderia pseudomallei T6SS identifies Hcp1 as a potential serodiagnostic marker. Microb Pathog. 79, 47\u201356 (2015).","journal-title":"Microb Pathog."},{"issue":"5","key":"48828_CR23","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.4269\/ajtmh.17-0791","volume":"98","author":"ZZ Win","year":"2018","unstructured":"Win, Z. Z. et al. Use of rapid enzyme-linked immunosorbent assays for serological screening of melioidosis in Myanmar. Am J Trop Med Hyg. 98(5), 1300\u20131302 (2018).","journal-title":"Am J Trop Med Hyg."},{"issue":"4","key":"48828_CR24","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.4269\/ajtmh.17-0885","volume":"98","author":"V Suttisunhakul","year":"2018","unstructured":"Suttisunhakul, V. et al. Retrospective analysis of fever and sepsis patients from cambodia reveals serological evidence of melioidosis. Am J Trop Med Hyg. 98(4), 1039\u20131045 (2018).","journal-title":"Am J Trop Med Hyg."},{"key":"48828_CR25","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3389\/fimmu.2014.00520","volume":"5","author":"G Vidarsson","year":"2014","unstructured":"Vidarsson, G., Dekkers, G. & Rispens, T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 5, 520 (2014).","journal-title":"Front Immunol."},{"issue":"3","key":"48828_CR26","first-page":"69","volume":"24","author":"MM Mukaka","year":"2012","unstructured":"Mukaka, M. M. Statistics Corner: A guide to appropriate use of Correlation coefficient in medical research. Malawi Med J. 24(3), 69\u201371 (2012).","journal-title":"Malawi Med J."},{"issue":"5","key":"48828_CR27","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1128\/JCM.02856-15","volume":"54","author":"V Suttisunhakul","year":"2016","unstructured":"Suttisunhakul, V. et al. Development of rapid enzyme-linked immunosorbent assays for detection of antibodies to Burkholderia pseudomallei. J Clin Microbiol. 54(5), 1259\u20131268 (2016).","journal-title":"J Clin Microbiol."},{"issue":"8","key":"48828_CR28","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1182\/blood-2011-04-345579","volume":"118","author":"MA Berkowska","year":"2011","unstructured":"Berkowska, M. A. et al. Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood. 118(8), 2150\u20132158 (2011).","journal-title":"Blood."},{"issue":"10","key":"48828_CR29","doi-asserted-by":"publisher","first-page":"e76767","DOI":"10.1371\/journal.pone.0076767","volume":"8","author":"MN Burtnick","year":"2013","unstructured":"Burtnick, M. N. & Brett, P. J. Burkholderia mallei and Burkholderia pseudomallei cluster 1 type VI secretion system gene expression is negatively regulated by iron and zinc. PLoS One. 8(10), e76767 (2013).","journal-title":"PLoS One."},{"issue":"5","key":"48828_CR30","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1128\/IAI.01544-14","volume":"82","author":"V Hopf","year":"2014","unstructured":"Hopf, V. et al. BPSS1504, a cluster 1 type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei. Infect Immun. 82(5), 2006\u20132015 (2014).","journal-title":"Infect Immun."},{"issue":"8","key":"48828_CR31","doi-asserted-by":"publisher","first-page":"3206","DOI":"10.1128\/IAI.01847-14","volume":"82","author":"AE Scott","year":"2014","unstructured":"Scott, A. E. et al. Burkholderia pseudomallei capsular polysaccharide conjugates provide protection against acute melioidosis. Infect Immun. 82(8), 3206\u20133213 (2014).","journal-title":"Infect Immun."},{"issue":"9","key":"48828_CR32","doi-asserted-by":"publisher","first-page":"e0203665","DOI":"10.1371\/journal.pone.0203665","volume":"13","author":"Rajna Mini\u0107","year":"2018","unstructured":"Minic, R. et al. Profiling of microorganism-binding serum antibody specificities in professional athletes. Plos One. 13(9) (2018).","journal-title":"PLOS ONE"},{"issue":"22","key":"48828_CR33","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1038\/emboj.2013.199","volume":"32","author":"S Panda","year":"2013","unstructured":"Panda, S., Zhang, J., Tan, N. S., Ho, B. & Ding, J. L. Natural IgG antibodies provide innate protection against ficolin-opsonized bacteria. Embo J. 32(22), 2905\u20132919 (2013).","journal-title":"Embo J."},{"key":"48828_CR34","doi-asserted-by":"crossref","unstructured":"Lim, C., Peacock, S. J. & Limmathurotsakul, D. Association between activities related to routes of infection and clinical manifestations of melioidosis. Clin Microbiol Infec. 22(1) (2016).","DOI":"10.1016\/j.cmi.2015.09.016"},{"key":"48828_CR35","doi-asserted-by":"crossref","unstructured":"See, J. X., Chandramathi, S., Abdulla, M. A., Vadivelu, J. & Shankar, E. M. Persistent infection due to a small-colony variant of Burkholderia pseudomallei leads to PD-1 upregulation on circulating immune cells and mononuclear infiltration in viscera of experimental BALB\/c mice. Plos Neglect Trop D. 11(8) (2017).","DOI":"10.1371\/journal.pntd.0005702"},{"issue":"7","key":"48828_CR36","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/89775","volume":"2","author":"AJS Macpherson","year":"2001","unstructured":"Macpherson, A. J. S. et al. IgA production without mu or delta chain expression in developing B cells. Nat Immun. 2(7), 625\u2013631 (2001).","journal-title":"Nat Immun."},{"issue":"2","key":"48828_CR37","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","volume":"125","author":"HW Schroeder","year":"2010","unstructured":"Schroeder, H. W. & Cavacini, L. Structure and function of immunoglobulins. J Allergy Clin Immun. 125(2), S41\u2013S52 (2010).","journal-title":"J Allergy Clin Immun."},{"issue":"4","key":"48828_CR38","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1086\/520441","volume":"29","author":"C Charuchaimontri","year":"1999","unstructured":"Charuchaimontri, C. et al. Antilipopolysaccharide II: an antibody protective against fatal melioidosis. Clin Infect Dis. 29(4), 813\u2013818 (1999).","journal-title":"Clin Infect Dis."},{"issue":"3","key":"48828_CR39","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1081-1206(10)60665-5","volume":"99","author":"S Agarwal","year":"2007","unstructured":"Agarwal, S. & Cunningham-Rundles, C. Assessment and clinical interpretation of reduced IgG values. Ann Allerg Asthma Im. 99(3), 281\u2013283 (2007).","journal-title":"Ann Allerg Asthma Im."},{"key":"48828_CR40","doi-asserted-by":"crossref","unstructured":"Taneja, V. Sex hormones determine immune response. Front Immunol. 9 (2018).","DOI":"10.3389\/fimmu.2018.01931"},{"key":"48828_CR41","doi-asserted-by":"crossref","unstructured":"Wu, B. N. & O\u2019Sullivan, A. J. Sex differences in energy metabolism need to be considered with lifestyle modifications in humans. J Nutr Metab. 391809 (2011).","DOI":"10.1155\/2011\/391809"},{"key":"48828_CR42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4049\/jimmunol.43.1.109","volume":"43","author":"ERI Von Haam","year":"1942","unstructured":"Von Haam, E. R. I. The effect of estrone on antibody-production. J Immunol. 43, 109\u2013117 (1942).","journal-title":"J Immunol."},{"key":"48828_CR43","doi-asserted-by":"crossref","unstructured":"Park, H. J. & Choi, J. M. Sex-specific regulation of immune responses by PPARs. Exp Mol Med. 49 (2017).","DOI":"10.1038\/emm.2017.102"},{"key":"48828_CR44","doi-asserted-by":"crossref","unstructured":"Sharon, J. P. Melioidosis. Trop Infec Dis. 219\u2013222 (2011).","DOI":"10.1016\/B978-0-7020-3935-5.00033-1"},{"issue":"3","key":"48828_CR45","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1159\/000443073","volume":"38","author":"X Zhai","year":"2016","unstructured":"Zhai, X. et al. Elevated B cell activation is associated with type 2 diabetes development in obese subjects. Cell Phys Biochem. 38(3), 1257\u20131266 (2016).","journal-title":"Cell Phys Biochem."},{"issue":"2","key":"48828_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1525-139X.1991.tb00429.x","volume":"4","author":"RA Rodby","year":"1991","unstructured":"Rodby, R. A. & Trenholme, G. M. Vaccination of dialysis patient. Semin Dial. 4(2), 102\u2013105 (1991).","journal-title":"Semin Dial."},{"key":"48828_CR47","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1053\/j.ajkd.2005.08.032","volume":"46","author":"M Dinis-Pensy","year":"2005","unstructured":"Dinis-Pensy, M. et al. The use of vaccines in adult patients with renal disease. Am J Kidney Dis. 46, 997\u20131011 (2005).","journal-title":"Am J Kidney Dis."},{"key":"48828_CR48","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1093\/ndt\/15.4.502","volume":"15","author":"G Fernandez-Fresnedo","year":"2000","unstructured":"Fernandez-Fresnedo, G. et al. B lymphopenia in uremia is related to an accelerated in vitro apoptosis and dysregulation of Bcl-2. Nephrol Dial Transplant. 15, 502\u2013510 (2000).","journal-title":"Nephrol Dial Transplant."},{"key":"48828_CR49","first-page":"259","volume":"19","author":"L Chatenoud","year":"1990","unstructured":"Chatenoud, L. et al. Immune deficiency of the uremic patient. Adv Nephrol Necker Hosp. 19, 259\u2013274 (1990).","journal-title":"Adv Nephrol Necker Hosp."},{"issue":"6","key":"48828_CR50","doi-asserted-by":"publisher","first-page":"434","DOI":"10.2165\/00003088-199222060-00003","volume":"22","author":"D Johnson","year":"1992","unstructured":"Johnson, D. & Fleming, S. The use of vaccines in renal failure. Clin Pharmacokinet. 22(6), 434\u2013446 (1992).","journal-title":"Clin Pharmacokinet."},{"issue":"1","key":"48828_CR51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/kisup.2012.72","volume":"3","author":"E Garabed","year":"2013","unstructured":"Garabed, E. et al. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidn Int Suppl. 3(1), 136\u2013150 (2013).","journal-title":"Kidn Int Suppl."},{"issue":"9","key":"48828_CR52","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1128\/iai.63.9.3348-3352.1995","volume":"63","author":"MB Perry","year":"1995","unstructured":"Perry, M. B., MacLean, L. L., Schollaardt, T., Bryan, L. E. & Ho, M. Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect Immun. 63(9), 3348\u20133352 (1995).","journal-title":"Infect Immun."},{"key":"48828_CR53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.carres.2013.08.013","volume":"381","author":"C Heiss","year":"2013","unstructured":"Heiss, C. et al. Revised structures for the predominant O-polysaccharides expressed by Burkholderia pseudomallei and Burkholderia mallei. Carbohydr Res. 381, 6\u201311 (2013).","journal-title":"Carbohydr Res."},{"key":"48828_CR54","doi-asserted-by":"crossref","unstructured":"Burtnick, M. N. et al. Development of capsular polysaccharide-based glycoconjugates for immunization against melioidosis and glanders. Frontiers in Cellular and Infection Microbiology 2 (2012).","DOI":"10.3389\/fcimb.2012.00108"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48828-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48828-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48828-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T19:45:49Z","timestamp":1695239149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48828-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48828"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48828-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]},"assertion":[{"value":"25 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13972"}}